Stable Isotopes- Adults With Obesity
University of Illinois at Urbana-Champaign · NCT07020741
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 19–59 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 8
- US sites recruiting
- 1
- Study start
- September 12, 2025
- Record last updated
- April 29, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
In a crossover design, 8 participants will receive caloric drinks containing stable isotopes. In one arm of the study, participants will consume 6 hourly drinks containing two stable isotopes. Repeated blood, breath, urine, and muscle biopsies will be taken. In the second arm, participants will consume 1 drink containing 75g glucose, labeled with two stable isotopes of glucose. Periodic blood and breath will be taken over three hours.
Being studied: Indispensable Amino Acid Oxidation; Stable Isotope Oral Glucose Tolerance Test
Conditions: Obese Patients (BMI ≥ 30 kg/m²); Glucose Metabolism; Protein Metabolism
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- ages 19-59
- Obese >/= 30 kg/m\^2 and >/= 102 cm for males and >/= 88 cm for females
- Godin Leisure-time or exercise questionnaire \<14 units
Exclusion Criteria
- Pregnant or become pregnant
- Any known food allergies
- Smoker
- Are physically active
- Have any known metabolic diseases
- Have been weight unstable within the last 6 months (lost or gained >10% of body mass)
- Non eumenorrheic or on a hormonal birth control
Recruiting US locations
Freer Hall - University of Illinois
Urbana, IL 61801
Site contact: Nicholas Burd (Associate Professor), PhD · 2172440970 · naburd@illinois.edu
Study contacts (from the official record)
- Nicholas Burd (Associate Professor), PhD · 2172440970 · naburd@illinois.edu
- Gena L Irwin (Research Assistant), M.S · 3608883281 · genai2@illinois.edu
Similar studies in Illinois
All weight loss studies in Illinois →- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- Skokie, IL + 51 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 2
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
AbbVie
- Location
- Chicago, IL + 58 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Alveus Therapeutics, Inc.
- Location
- Champaign, IL + 19 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass
Boston Scientific Corporation
- Location
- Chicago, IL + 8 other US sites
- Eligibility basics
- Ages 18+